V022-2331 Screening compound: 2-(2-chlorophenyl)-4-(3-chlorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

V022-2331 Screening compound: 2-(2-chlorophenyl)-4-(3-chlorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine
V022-2331 Screening compound: 2-(2-chlorophenyl)-4-(3-chlorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-2331
2-(2-chlorophenyl)-4-(3-chlorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-2331

Molecular Formula

C21H18Cl2N6O (C21 H18 Cl2 N6 O)

Compound Name

2-(2-chlorophenyl)-4-(3-chlorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

IUPAC name

2-(2-chlorophenyl)-4-(3-chlorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[34-d]pyrimidin-3-amine

SMILES

Nc1c2c(-c3cc(Cl)ccc3)nc(N3CCOCC3)nc2nn1-c(cccc1)c1Cl

InChI

InChI=1S/C21H18Cl2N6O/c22-14-5-3-4-13(12-14)18-17-19(24)29(16-7-2-1-6-15(16)23)27-20(17)26-21(25-18)28-8-10-30-11-9-28/h1-7,12H,8-11,24H2

InChI Key

IKTFVRIXZSCQSR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14249229

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

441.32

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.821

Distribution Coefficient, logD

4.820

Water Solubility, LogSw

-5.00

Polar Surface Area

63.429

Acid Dissociation Constant (pKa)

19.75

Base Dissociation Constant (pKb)

4.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

V022-2331 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V022-2331 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-2331?
Check Price and Availability of V022-2331, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-2331 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-2331
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-2331
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-2331 available by request